Summary

Oral Appliances Market Growth & Trends

The global oral appliances market size is expected to reach USD 1.4 billion by 2030, at a projected CAGR of 5.72% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by rising awareness of sleep disorders, such as obstructive sleep apnea (OSA), and the growing preference for non-invasive treatment options. Technological advancements, including custom 3D printing and integration with digital health tools, enhance the effectiveness and comfort of these devices. Increasing demand for alternatives to continuous positive airway pressure (CPAP) therapy and supportive regulatory environments also contribute to market expansion.

Increasing awareness about sleep disorders and their impact on overall health has further driven demand for effective solutions like MADs. These devices are specifically designed to address obstructive sleep apnea and snoring by advancing the lower jaw to maintain an open airway during sleep. In addition, the growing preference for non-invasive treatment options over more cumbersome alternatives, such as CPAP machines, has bolstered MAD adoption. Technological advancements have significantly improved the comfort, effectiveness, and customization of these devices. Moreover, rising disposable income and expanded healthcare coverage have made MADs more accessible to a broader population, further contributing to market growth.

The transition from PAP devices to oral appliances is driven by a combination of enhanced comfort, ease of use, positive clinical outcomes, and patient satisfaction. Feedback from lapsed PAP users highlights the effectiveness of oral appliances in improving sleep quality and overall user experience. This shift indicates a strong user preference for oral appliances, contributing to their increasing market adoption. These insights provide a solid foundation for understanding the adoption trends and patient preferences in the market.

• Trend Insight: One of the primary reasons lapsed PAP (Positive Airway Pressure) users are transitioning to oral appliances is the comfort and convenience offered by these devices. Unlike PAP machines, which can be bulky and uncomfortable, oral appliances are compact and easier to wear.

• Instance: A study published in the Journal of Clinical Sleep Medicine highlighted that over 60% of former PAP users reported improved comfort and ease of use with oral appliances. This shift is particularly notable among patients who experienced discomfort or intolerance with PAP masks.

Furthermore, the growing awareness and accessibility contribute to the market growth. There is a growing awareness of oral appliances as a viable alternative to PAP devices. This is coupled with increased accessibility due to advancements in dental technology and more dental practitioners offering these solutions. For instance, according to a survey by the American Academy of Dental Sleep Medicine, there has been a 35% increase in the number of dental practices offering oral appliance therapy over the past five years. This surge has facilitated easier access for patients seeking alternatives to PAP therapy.

Oral Appliances Market Report Highlights

• Based on product, the MADs segment dominated the market with the largest revenue share of 69.0% in 2023. This growth is primarily driven by increasing regulatory approvals and clearances, which enhance the credibility and market reach of these devices.

• In terms of indication, the mild-to-moderate OSA segment dominated the market with the largest revenue share in 2023. The segment dominated the market due to the high prevalence of these conditions and the effectiveness of oral appliances in managing them.

• Based on end use, the hospitals & clinics segment dominated the market in 2023. This growth is due to their central role in diagnosing and managing sleep disorders like OSA.

• On the basis of distribution channel, theDirect-to-Consumer (DTC) segment dominated the market with the largest revenue share in 2023. The segment dominated the market due to increasing consumer preference for convenient, at-home healthcare solutions and the growing availability of online purchasing platforms.

• North America held the largest global market share in 2023. Changing lifestyles, growing disposable income, presence of renowned players, growing obese population, growing awareness about OSA, and favorable government initiatives are some of the key factors driving the growth.

• Major players are employing various strategies such as product launches, collaborations, acquisitions, and mergers to expand their service portfolios and enhance their geographical presence, leading to significant competition within the market. For example, in September 2023, ResMed announced a strategic partnership with Nyxoah to increase awareness of obstructive sleep apnea and boost therapy penetration in Germany, contributing to market growth during the forecast period.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product outlook
1.1.2. Indication
1.1.3. End Use
1.1.4. Distribution Channel
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Indication
2.2.3. End Use
2.2.4. Distribution Channel
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Oral Appliances Market Variables, Trends & Scope
3.1. Market Dynamics
3.1.1. Market driver analysis
3.1.2. Market restraint analysis
3.1.3. Market Opportunities
3.2. Oral Appliances Market Analysis Tools
3.2.1. Industry Analysis - Porter’s
3.2.1.1. Supplier power
3.2.1.2. Buyer power
3.2.1.3. Substitution threat
3.2.1.4. Threat of new entrant
3.2.1.5. Competitive rivalry
3.2.2. PESTEL Analysis
3.2.2.1. Political landscape
3.2.2.2. Economic landscape
3.2.2.3. Social landscape
3.2.2.4. Technological landscape
3.2.2.5. Environmental landscape
3.2.2.6. Legal landscape
3.2.3. COVID-19 Impact Analysis
Chapter 4. Oral Appliances Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Oral Appliances Market by Product Outlook
4.4. Mandibular Advancement Devices (MADs)
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Tongue Retaining Devices (TRDs)
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Hybrid Devices
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Oral Appliances Market: Indication Estimates & Trend Analysis
5.1. Indication Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Oral Appliances Market by Indication Outlook
5.4. Mild to Moderate Obstructive Sleep Apnea (OSA)
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Severe Obstructive Sleep Apnea (OSA)
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Snoring
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Oral Appliances Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Oral Appliances Market by End Use Outlook
6.4. Homecare
6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. Hospitals & Clinics
6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Oral Appliances Market: Distribution Channel Estimates & Trend Analysis
7.1. Distribution Channel Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Oral Appliances Market by Distribution Channel Outlook
7.4. Direct-to-Consumer (Online and Offline)
7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.5. Hospitals & Clinics
7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.6. Others
7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Oral Appliances Market: Regional Estimates & Trend Analysis, By Type
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. U.S.
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Canada
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. UK
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Germany
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. France
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Italy
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework/ reimbursement structure
8.6.4.3. Competitive scenario
8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Spain
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework/ reimbursement structure
8.6.5.3. Competitive scenario
8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Norway
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework/ reimbursement structure
8.6.6.3. Competitive scenario
8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Sweden
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework/ reimbursement structure
8.6.7.3. Competitive scenario
8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Denmark
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework/ reimbursement structure
8.6.8.3. Competitive scenario
8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Japan
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. China
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. India
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Australia
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. South Korea
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework/ reimbursement structure
8.7.5.3. Competitive scenario
8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. Thailand
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework/ reimbursement structure
8.7.6.3. Competitive scenario
8.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework/ reimbursement structure
8.8.1.3. Competitive scenario
8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Argentina
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework/ reimbursement structure
8.8.2.3. Competitive scenario
8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
8.9.1. South Africa
8.9.1.1. Key country dynamics
8.9.1.2. Regulatory framework/ reimbursement structure
8.9.1.3. Competitive scenario
8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.2. Saudi Arabia
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework/ reimbursement structure
8.9.2.3. Competitive scenario
8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. UAE
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework/ reimbursement structure
8.9.3.3. Competitive scenario
8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. Kuwait
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework/ reimbursement structure
8.9.4.3. Competitive scenario
8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Key company market share/position analysis, 2023
9.4. Company Profiles
9.4.1. ResMed Inc.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Technology Type benchmarking
9.4.1.4. Strategic initiatives
9.4.2. ProSomnus
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Technology Type benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Vivos
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Technology Type benchmarking
9.4.3.4. Strategic initiatives
9.4.4. SomnoMed.com
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Technology Type benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Glidewell
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Technology Type benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Airway Management (TAP)
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Technology Type benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Mitsui Chemicals, Inc. (Whole You)
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Technology Type benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Achaemenid, LLC
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Technology Type benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Apnea Sciences
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Technology Type benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Signifier Medical Technologies
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Technology Type benchmarking
9.4.10.4. Strategic initiatives
9.4.11. GoodSleepCo
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Technology Type benchmarking
9.4.11.4. Strategic initiatives